Physician

Muhammad Owais Hanif, MD

According to 2025 Medicare claims, Muhammad Hanif, MD (NPI: 1144731100) practices nephrology in the Salisbury, MD market, with the plurality of this provider's patient population coming from Wicomico, MD. This provider's primary affiliated billing organization is PENINSULA NEPHROLOGY ASSOCIATES, PA (NPI: 1811916976; TIN: 521068452) and primary practice location at 21804-1664.

Hanif's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,442 traditional Medicare patients, billed 7,118 HCPCS/CPT codes, and received $617,290 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 515 prescription claims across 236 beneficiaries totaling $123,221 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). Open Payments data shows 17 records totaling $380. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,616 to $123,221. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$309K$617K2022 Medicare payment: $250,150 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $574,526 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $617,290 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20227762,359$250,150
20231,3195,777$574,526
20241,4427,118$617,290

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$62K$123K2018 Drug cost: $5,616 (USD; Tot_Drug_Cst)2019 Drug cost: $1,603 (USD; Tot_Drug_Cst)2020 Drug cost: $6,945 (USD; Tot_Drug_Cst)2021 Drug cost: $13,204 (USD; Tot_Drug_Cst)2022 Drug cost: $29,647 (USD; Tot_Drug_Cst)2023 Drug cost: $95,628 (USD; Tot_Drug_Cst)2024 Drug cost: $123,221 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181142$5,616
201920105$1,603
20202976$6,945
202166208$13,204
202282184$29,647
2023194435$95,628
2024236515$123,221

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes371462$128
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7361,103$95
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes5292,125$91
99457Management using the results of remote vital sign monitoring per calendar month, first 20 minutes184548$39
99458Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes170454$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VelphoroSucroferric Oxyhydroxide11630$37,894
JardianceEmpagliflozin411,911$37,020
VeltassaPatiromer Calcium Sorbitex15682$12,078
KerendiaFinerenone12450$9,214
FarxigaDapagliflozin Propanediol12600$8,928

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$380Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Muhammad Owais Hanif, MD?

Tedicare shows public-source Medicare data for Muhammad Owais Hanif, MD (NPI 1144731100), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Muhammad Owais Hanif, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Muhammad Owais Hanif, MD?

Muhammad Owais Hanif, MD is linked to PENINSULA NEPHROLOGY ASSOCIATES, PA (billing NPI 1811916976) in the available physician profile data.

Does Muhammad Owais Hanif, MD have Open Payments data?

Muhammad Owais Hanif, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.